Dutee Chand, the holder of a national record, has received a four-year ban due to failing an out-of-competition dope test. Dutee achieved the distinction of establishing a new women’s record in India by completing the 100m race in 11.17 seconds at the 2021 Indian Grand Prix 4.
The prohibition has been in effect from January 3, 2023, and any achievements in competitive events acquired since the sample collection date (December 5, 2022) will be invalidated.
The publication cited a statement from the Anti-Doping Disciplinary Panel (ADDP) which conveyed:
“The athlete though has satisfied the panel with the source of ingestion of the prohibited substance but was not able to establish the no significant fault or negligence.”
ADDP noted that Dutee has not succeeded in demonstrating that the breach of the rule was accidental. The directive issued by Chaitanya Mahajan, who leads the ADDP, stated as follows:
“In view of the totality of circumstances, the athlete has failed to establish that the said anti doping rule violation (ADRV) was unintentional due to following reasons: 1) The athlete instead of consulting a physician allegedly consulted her physiotherapist and consumed the medicines prescribed by her. 2) The athlete did not check the label with respect to the contents of the medicine consumed by her. 3) The athlete didn’t cross check the contents of the drugs with the latest published lists of prohibited substances by WADA.”
Dutee underwent two rounds of testing conducted by the National Anti-Doping Agency (NADA) in December 2022. Following a confirmation of prohibited anabolic steroid usage in her tests, she received a temporary suspension. The collected sample exhibited adverse analytical results (AAF) for the substances known as ‘andarine,’ ‘ostarine,’ and ‘ligandrol’.
Also Read | Top 10 Nike sports shoes